发明名称 THERAPEUTIC AGENT FOR HEPATITIS C
摘要 <p>Disclosed is a novel therapeutic agent for hepatitis C, which has a high therapeutic effect on hepatitis C.  The therapeutic agent for hepatitis C comprises hydroxyurea as an active ingredient.  The therapeutic agent for hepatitis C may additionally comprise interferon-a.  The novel therapeutic agent for hepatitis C has a high therapeutic effect on hepatitis C.  The use of interferon-a in combination can achieve a synergistic effect for the treatment of hepatitis C.  When a patient is infected by a hepatitis C virus having a genotype on which interferon-a therapy is effective, the therapeutic effect on the patient can be further increased by using interferon-a in combination.</p>
申请公布号 WO2010044474(A1) 申请公布日期 2010.04.22
申请号 WO2009JP67942 申请日期 2009.10.16
申请人 PUBLIC UNIVERSITY CORPORATION YOKOHAMA CITY UNIVERSITY;NATIONAL UNIVERSITY CORPORATION OKAYAMA UNIVERSITY;NOZAKI, AKITO;TANAKA, KATSUAKI;IKEDA, MASANORI;KATO, NOBUYUKI 发明人 NOZAKI, AKITO;TANAKA, KATSUAKI;IKEDA, MASANORI;KATO, NOBUYUKI
分类号 A61K31/17;A61K38/21;A61P1/16;A61P31/14;A61P43/00 主分类号 A61K31/17
代理机构 代理人
主权项
地址